Loading clinical trials...
Loading clinical trials...
Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia
Conditions
Interventions
Allogeneic NK transfer
Locations
2
Colombia
Fundacion Salud De Los Andes
Bogotá, Bogotá Distrito Capital, Colombia
Universidad Nacional de Colombia
Bogota, Cundinamarca, Colombia
Start Date
March 30, 2020
Primary Completion Date
June 30, 2020
Completion Date
October 30, 2020
Last Updated
May 5, 2021
NCT06721949
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
Universidad Nacional de Colombia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions